

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | type B pancreatic cell development (GO:0003323) | 6.25743899 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.42021337 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.42021337 |
| 4 | glandular epithelial cell development (GO:0002068) | 5.34818735 |
| 5 | endocrine pancreas development (GO:0031018) | 5.22346956 |
| 6 | glandular epithelial cell differentiation (GO:0002067) | 4.91984543 |
| 7 | peptide hormone processing (GO:0016486) | 4.71154468 |
| 8 | mesodermal cell differentiation (GO:0048333) | 4.66310543 |
| 9 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.64642438 |
| 10 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.62202041 |
| 11 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.52817121 |
| 12 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.35559911 |
| 13 | endocardial cushion development (GO:0003197) | 4.33811250 |
| 14 | thrombin receptor signaling pathway (GO:0070493) | 4.28179940 |
| 15 | pericardium development (GO:0060039) | 4.22949723 |
| 16 | cellular response to vitamin D (GO:0071305) | 4.13108623 |
| 17 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.10537184 |
| 18 | response to hepatocyte growth factor (GO:0035728) | 4.10537184 |
| 19 | exocrine pancreas development (GO:0031017) | 4.02344210 |
| 20 | extracellular matrix assembly (GO:0085029) | 3.97114744 |
| 21 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.88460037 |
| 22 | fibroblast migration (GO:0010761) | 3.85852450 |
| 23 | chondrocyte proliferation (GO:0035988) | 3.77303587 |
| 24 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.75626120 |
| 25 | kidney mesenchyme development (GO:0072074) | 3.69281079 |
| 26 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.67345422 |
| 27 | negative regulation of hormone metabolic process (GO:0032351) | 3.67345422 |
| 28 | type B pancreatic cell proliferation (GO:0044342) | 3.65464567 |
| 29 | protein targeting to Golgi (GO:0000042) | 3.64067199 |
| 30 | COPII vesicle coating (GO:0048208) | 3.59537276 |
| 31 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.59111582 |
| 32 | ganglion development (GO:0061548) | 3.58164586 |
| 33 | detection of calcium ion (GO:0005513) | 3.55278699 |
| 34 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.55099040 |
| 35 | sequestering of metal ion (GO:0051238) | 3.54712830 |
| 36 | collagen fibril organization (GO:0030199) | 3.53676420 |
| 37 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.49806515 |
| 38 | smooth muscle tissue development (GO:0048745) | 3.48677118 |
| 39 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.47767864 |
| 40 | insulin secretion (GO:0030073) | 3.47744212 |
| 41 | positive regulation of fibroblast migration (GO:0010763) | 3.45804486 |
| 42 | platelet aggregation (GO:0070527) | 3.45551260 |
| 43 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.45287080 |
| 44 | extracellular fibril organization (GO:0043206) | 3.41407795 |
| 45 | negative regulation of protein localization to cell surface (GO:2000009) | 3.38308393 |
| 46 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.36455020 |
| 47 | inner ear receptor cell development (GO:0060119) | 3.35989227 |
| 48 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.35160673 |
| 49 | metanephric mesenchyme development (GO:0072075) | 3.34110137 |
| 50 | signal peptide processing (GO:0006465) | 3.31766170 |
| 51 | ER overload response (GO:0006983) | 3.30676614 |
| 52 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.28549830 |
| 53 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.28549830 |
| 54 | protein localization to cell surface (GO:0034394) | 3.28236902 |
| 55 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.26401265 |
| 56 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.26090734 |
| 57 | bone trabecula formation (GO:0060346) | 3.23312223 |
| 58 | intestinal epithelial cell development (GO:0060576) | 3.22522104 |
| 59 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.22246698 |
| 60 | cell migration involved in heart development (GO:0060973) | 3.20760407 |
| 61 | intestinal absorption (GO:0050892) | 3.20033631 |
| 62 | relaxation of smooth muscle (GO:0044557) | 3.19504082 |
| 63 | dorsal/ventral axis specification (GO:0009950) | 3.19071990 |
| 64 | protein localization to Golgi apparatus (GO:0034067) | 3.18109871 |
| 65 | somite development (GO:0061053) | 3.17521833 |
| 66 | lung lobe morphogenesis (GO:0060463) | 3.16676546 |
| 67 | membrane repolarization during action potential (GO:0086011) | 3.15025745 |
| 68 | toxin metabolic process (GO:0009404) | 3.14335057 |
| 69 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.13500994 |
| 70 | positive regulation of receptor recycling (GO:0001921) | 3.13451853 |
| 71 | establishment of protein localization to Golgi (GO:0072600) | 3.13043807 |
| 72 | protein maturation by protein folding (GO:0022417) | 3.12083591 |
| 73 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.10742345 |
| 74 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.09178578 |
| 75 | lung vasculature development (GO:0060426) | 3.09001991 |
| 76 | embryonic foregut morphogenesis (GO:0048617) | 3.08903840 |
| 77 | endodermal cell differentiation (GO:0035987) | 3.07175460 |
| 78 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.04780171 |
| 79 | protein heterotrimerization (GO:0070208) | 3.04705264 |
| 80 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.00716699 |
| 81 | negative chemotaxis (GO:0050919) | 3.00189395 |
| 82 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.98092820 |
| 83 | anterior/posterior axis specification, embryo (GO:0008595) | 2.95932455 |
| 84 | positive regulation of insulin secretion (GO:0032024) | 2.93947414 |
| 85 | pancreas development (GO:0031016) | 2.93069613 |
| 86 | regulation of insulin secretion (GO:0050796) | 2.92999098 |
| 87 | tonic smooth muscle contraction (GO:0014820) | 2.92838690 |
| 88 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.89730172 |
| 89 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.89539822 |
| 90 | polarized epithelial cell differentiation (GO:0030859) | 2.88879251 |
| 91 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.86698410 |
| 92 | respiratory tube development (GO:0030323) | 2.86435727 |
| 93 | hypotonic response (GO:0006971) | 2.86194741 |
| 94 | establishment of apical/basal cell polarity (GO:0035089) | 2.83078371 |
| 95 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.81852155 |
| 96 | fibril organization (GO:0097435) | 2.81692331 |
| 97 | positive regulation of nuclease activity (GO:0032075) | 2.81339597 |
| 98 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.80899230 |
| 99 | induction of positive chemotaxis (GO:0050930) | 2.80842570 |
| 100 | muscle cell migration (GO:0014812) | 2.80408887 |
| 101 | sphingosine metabolic process (GO:0006670) | 2.78895685 |
| 102 | negative regulation of norepinephrine secretion (GO:0010700) | 2.77517406 |
| 103 | cellular response to vitamin (GO:0071295) | 2.77371100 |
| 104 | regulation of glucocorticoid secretion (GO:2000849) | 2.76684352 |
| 105 | SMAD protein complex assembly (GO:0007183) | 2.76394964 |
| 106 | peptide hormone secretion (GO:0030072) | 2.75365665 |
| 107 | regulation of glomerular filtration (GO:0003093) | 2.73765188 |
| 108 | platelet degranulation (GO:0002576) | 2.73356192 |
| 109 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.72906433 |
| 110 | extracellular regulation of signal transduction (GO:1900115) | 2.72544721 |
| 111 | extracellular negative regulation of signal transduction (GO:1900116) | 2.72544721 |
| 112 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.71944188 |
| 113 | peptide secretion (GO:0002790) | 2.71873046 |
| 114 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.70069248 |
| 115 | dermatan sulfate biosynthetic process (GO:0030208) | 2.69951929 |
| 116 | mesenchymal cell differentiation (GO:0048762) | 2.69590644 |
| 117 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.69472554 |
| 118 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.69437538 |
| 119 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.69055331 |
| 120 | diol metabolic process (GO:0034311) | 2.68771046 |
| 121 | prostate gland growth (GO:0060736) | 2.68248479 |
| 122 | surfactant homeostasis (GO:0043129) | 2.67797096 |
| 123 | protein retention in ER lumen (GO:0006621) | 2.66980766 |
| 124 | vesicle coating (GO:0006901) | 2.66868275 |
| 125 | cell differentiation involved in metanephros development (GO:0072202) | 2.66198849 |
| 126 | hippo signaling (GO:0035329) | 2.65308845 |
| 127 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.64905008 |
| 128 | histone H3-K36 demethylation (GO:0070544) | 2.64689660 |
| 129 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.64049870 |
| 130 | negative regulation of platelet activation (GO:0010544) | 2.63166948 |
| 131 | cell adhesion mediated by integrin (GO:0033627) | 2.62264637 |
| 132 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.61631940 |
| 133 | myelin assembly (GO:0032288) | 2.61219622 |
| 134 | negative regulation of stem cell proliferation (GO:2000647) | 2.61108448 |
| 135 | regulation of peptide hormone secretion (GO:0090276) | 2.59515637 |
| 136 | regulation of keratinocyte proliferation (GO:0010837) | 2.59197784 |
| 137 | regulation of nuclease activity (GO:0032069) | 2.59010231 |
| 138 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.55982869 |
| 139 | negative regulation of osteoblast proliferation (GO:0033689) | 2.54954362 |
| 140 | coronary vasculature morphogenesis (GO:0060977) | 2.53386856 |
| 141 | regulation of peptide secretion (GO:0002791) | 2.53083334 |
| 142 | gland morphogenesis (GO:0022612) | 2.52389085 |
| 143 | lung alveolus development (GO:0048286) | 2.50435795 |
| 144 | regulation of lipoprotein metabolic process (GO:0050746) | 2.49007528 |
| 145 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.48740318 |
| 146 | regulation of platelet aggregation (GO:0090330) | 2.47336925 |
| 147 | positive regulation of bone mineralization (GO:0030501) | 2.46912734 |
| 148 | cell-substrate junction assembly (GO:0007044) | 2.46704620 |
| 149 | negative regulation of bone resorption (GO:0045779) | 2.46260982 |
| 150 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.46141182 |
| 151 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.45366447 |
| 152 | negative regulation of catecholamine secretion (GO:0033604) | 2.45328562 |
| 153 | regulation of hormone biosynthetic process (GO:0046885) | 2.45162050 |
| 154 | regulation of focal adhesion assembly (GO:0051893) | 2.45065575 |
| 155 | regulation of cell-substrate junction assembly (GO:0090109) | 2.45065575 |
| 156 | hindbrain development (GO:0030902) | 2.44624176 |
| 157 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.44592947 |
| 158 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.43642956 |
| 159 | cellular response to unfolded protein (GO:0034620) | 2.43520157 |
| 160 | embryonic eye morphogenesis (GO:0048048) | 2.43303545 |
| 161 | cell-matrix adhesion (GO:0007160) | 2.42619925 |
| 162 | negative regulation of insulin secretion (GO:0046676) | 2.42491188 |
| 163 | regulation of osteoblast proliferation (GO:0033688) | 2.42296356 |
| 164 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.42030935 |
| 165 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.41863122 |
| 166 | midgut development (GO:0007494) | 2.41802448 |
| 167 | regulation of vitamin metabolic process (GO:0030656) | 2.41373658 |
| 168 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 2.40757466 |
| 169 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.40570712 |
| 170 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.40493738 |
| 171 | establishment of monopolar cell polarity (GO:0061162) | 2.40493738 |
| 172 | regulation of cardioblast proliferation (GO:0003264) | 2.40053905 |
| 173 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.40053905 |
| 174 | intestinal cholesterol absorption (GO:0030299) | 2.39995594 |
| 175 | regulation of smooth muscle cell migration (GO:0014910) | 2.39535043 |
| 176 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.39372195 |
| 177 | regulation of male gonad development (GO:2000018) | 2.39212894 |
| 178 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.38286376 |
| 179 | positive regulation of catenin import into nucleus (GO:0035413) | 2.38256150 |
| 180 | dermatan sulfate metabolic process (GO:0030205) | 2.38167035 |
| 181 | lipid translocation (GO:0034204) | 2.37886845 |
| 182 | phospholipid translocation (GO:0045332) | 2.37886845 |
| 183 | peptide transport (GO:0015833) | 2.36994848 |
| 184 | negative regulation of focal adhesion assembly (GO:0051895) | 2.35022663 |
| 185 | negative regulation of cell junction assembly (GO:1901889) | 2.35022663 |
| 186 | negative regulation of adherens junction organization (GO:1903392) | 2.35022663 |
| 187 | positive regulation of focal adhesion assembly (GO:0051894) | 2.34409252 |
| 188 | positive regulation of cell junction assembly (GO:1901890) | 2.34409252 |
| 189 | regulation of adherens junction organization (GO:1903391) | 2.34221828 |
| 190 | cGMP-mediated signaling (GO:0019934) | 2.32786687 |
| 191 | phagocytosis, engulfment (GO:0006911) | 2.32054474 |
| 192 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.31205777 |
| 193 | adrenal gland development (GO:0030325) | 2.30295873 |
| 194 | blood vessel maturation (GO:0001955) | 2.29591113 |
| 195 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.29533075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.48313141 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.31695282 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.07167994 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61707165 |
| 5 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.28069965 |
| 6 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.28069965 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24387731 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.18627760 |
| 9 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.16181237 |
| 10 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.13803404 |
| 11 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.07933691 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.06269470 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.06085457 |
| 14 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.96570208 |
| 15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.94918965 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.92230007 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91620298 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.87285609 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.83597802 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80809339 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74869200 |
| 22 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73615924 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73193399 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72284737 |
| 25 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.69253354 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.61394589 |
| 27 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60282441 |
| 28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59988605 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59294366 |
| 30 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.58761091 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53174663 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.52977925 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52124814 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51915705 |
| 35 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.51155759 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50679935 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49158087 |
| 38 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47714906 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45235238 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43362909 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41181020 |
| 42 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39826036 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37450846 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.35401086 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35180551 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34940185 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34772140 |
| 48 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.34748584 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34260265 |
| 50 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33949653 |
| 51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.33698799 |
| 52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32479638 |
| 53 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31274142 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30887461 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30797588 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30343813 |
| 57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29605813 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.29331416 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.29331416 |
| 60 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29176002 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28457545 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26977027 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26786281 |
| 64 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26571079 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26281694 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25863901 |
| 67 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.24211497 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23931866 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21883242 |
| 70 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21853432 |
| 71 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21755642 |
| 72 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21273390 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20905895 |
| 74 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20759653 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20360315 |
| 76 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20096620 |
| 77 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19398722 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19296241 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18998342 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18796848 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18716030 |
| 82 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.18645658 |
| 83 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18085444 |
| 84 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17575352 |
| 85 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.17302363 |
| 86 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.17112280 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16757358 |
| 88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16533716 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16208004 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15906230 |
| 91 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15751141 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15366053 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15075504 |
| 94 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.14934398 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14727732 |
| 96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13938418 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13627716 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12747516 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12339882 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11078428 |
| 101 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10305551 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10296318 |
| 103 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.09692228 |
| 104 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09564651 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09383614 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08486698 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08186093 |
| 108 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07944898 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07771041 |
| 110 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07606672 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07472881 |
| 112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07265003 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07153809 |
| 114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07071819 |
| 115 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06628189 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06604157 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06028427 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05583749 |
| 119 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.05341614 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04737973 |
| 121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04300943 |
| 122 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03866710 |
| 123 | AR_19668381_ChIP-Seq_PC3_Human | 1.03595030 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03093582 |
| 125 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03047052 |
| 126 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02803098 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02738351 |
| 128 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02512270 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02283348 |
| 130 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.02185525 |
| 131 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02109938 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00436107 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00222276 |
| 134 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99705695 |
| 135 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99366919 |
| 136 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99136798 |
| 137 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97912780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 4.56141008 |
| 2 | MP0003283_abnormal_digestive_organ | 4.34343171 |
| 3 | MP0005275_abnormal_skin_tensile | 4.19906595 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 4.10793345 |
| 5 | MP0000678_abnormal_parathyroid_gland | 3.85901750 |
| 6 | MP0003566_abnormal_cell_adhesion | 3.28227985 |
| 7 | MP0003279_aneurysm | 3.25025563 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 3.12214509 |
| 9 | MP0002693_abnormal_pancreas_physiology | 3.05872971 |
| 10 | MP0008004_abnormal_stomach_pH | 3.02615873 |
| 11 | MP0001944_abnormal_pancreas_morphology | 2.93689209 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.88670579 |
| 13 | MP0000462_abnormal_digestive_system | 2.86950878 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.80562296 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.60415443 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.54401778 |
| 17 | MP0004043_abnormal_pH_regulation | 2.48314862 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.40687208 |
| 19 | MP0005379_endocrine/exocrine_gland_phen | 2.37871879 |
| 20 | MP0000516_abnormal_urinary_system | 2.36516081 |
| 21 | MP0005367_renal/urinary_system_phenotyp | 2.36516081 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.32114756 |
| 23 | MP0006054_spinal_hemorrhage | 2.28058684 |
| 24 | MP0009384_cardiac_valve_regurgitation | 2.14538854 |
| 25 | MP0004084_abnormal_cardiac_muscle | 2.12914980 |
| 26 | MP0003091_abnormal_cell_migration | 2.00017997 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.93987901 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.92676706 |
| 29 | MP0000566_synostosis | 1.90534395 |
| 30 | MP0002896_abnormal_bone_mineralization | 1.87540041 |
| 31 | MP0001879_abnormal_lymphatic_vessel | 1.84073112 |
| 32 | MP0001188_hyperpigmentation | 1.79609315 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.78422481 |
| 34 | MP0002295_abnormal_pulmonary_circulatio | 1.77909443 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 1.76485293 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.73207628 |
| 37 | MP0000767_abnormal_smooth_muscle | 1.72853149 |
| 38 | MP0001270_distended_abdomen | 1.70003975 |
| 39 | MP0000537_abnormal_urethra_morphology | 1.69808492 |
| 40 | MP0005023_abnormal_wound_healing | 1.67050271 |
| 41 | MP0005595_abnormal_vascular_smooth | 1.65145860 |
| 42 | MP0001542_abnormal_bone_strength | 1.61512479 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.61254217 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.60718971 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.60577281 |
| 46 | MP0003787_abnormal_imprinting | 1.58287433 |
| 47 | MP0003122_maternal_imprinting | 1.57794554 |
| 48 | MP0000613_abnormal_salivary_gland | 1.53489766 |
| 49 | MP0003119_abnormal_digestive_system | 1.51859942 |
| 50 | MP0003941_abnormal_skin_development | 1.50389109 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.48468817 |
| 52 | MP0005171_absent_coat_pigmentation | 1.48408383 |
| 53 | MP0000538_abnormal_urinary_bladder | 1.47945511 |
| 54 | MP0004272_abnormal_basement_membrane | 1.45491978 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.39480663 |
| 56 | MP0004134_abnormal_chest_morphology | 1.38930051 |
| 57 | MP0005248_abnormal_Harderian_gland | 1.38398962 |
| 58 | MP0003045_fibrosis | 1.34659173 |
| 59 | MP0003868_abnormal_feces_composition | 1.31817487 |
| 60 | MP0002108_abnormal_muscle_morphology | 1.28959266 |
| 61 | MP0002638_abnormal_pupillary_reflex | 1.27564017 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.26894987 |
| 63 | MP0002128_abnormal_blood_circulation | 1.26705224 |
| 64 | MP0001664_abnormal_digestion | 1.26698331 |
| 65 | MP0000631_abnormal_neuroendocrine_gland | 1.24113643 |
| 66 | MP0002254_reproductive_system_inflammat | 1.23997342 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.23001747 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.21587281 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.21254666 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.21215101 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.20247917 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.19971696 |
| 73 | MP0003195_calcinosis | 1.19311816 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.19153532 |
| 75 | MP0009250_abnormal_appendicular_skeleto | 1.18120888 |
| 76 | MP0005187_abnormal_penis_morphology | 1.17505044 |
| 77 | MP0003866_abnormal_defecation | 1.16630635 |
| 78 | MP0000534_abnormal_ureter_morphology | 1.15236976 |
| 79 | MP0002009_preneoplasia | 1.14549513 |
| 80 | MP0008775_abnormal_heart_ventricle | 1.14197404 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 1.14193057 |
| 82 | MP0003935_abnormal_craniofacial_develop | 1.11947878 |
| 83 | MP0002928_abnormal_bile_duct | 1.11633265 |
| 84 | MP0004510_myositis | 1.10403354 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 1.08249573 |
| 86 | MP0005164_abnormal_response_to | 1.07857617 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 1.07504077 |
| 88 | MP0001299_abnormal_eye_distance/ | 1.06891700 |
| 89 | MP0000470_abnormal_stomach_morphology | 1.06621777 |
| 90 | MP0002177_abnormal_outer_ear | 1.04863052 |
| 91 | MP0003937_abnormal_limbs/digits/tail_de | 1.04335079 |
| 92 | MP0005503_abnormal_tendon_morphology | 1.03697298 |
| 93 | MP0002938_white_spotting | 1.03530482 |
| 94 | MP0003121_genomic_imprinting | 1.03056866 |
| 95 | MP0005646_abnormal_pituitary_gland | 1.02876143 |
| 96 | MP0003385_abnormal_body_wall | 1.02517099 |
| 97 | MP0003115_abnormal_respiratory_system | 1.01676900 |
| 98 | MP0001958_emphysema | 1.01214879 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.99483372 |
| 100 | MP0000751_myopathy | 0.98312695 |
| 101 | MP0000428_abnormal_craniofacial_morphol | 0.98086921 |
| 102 | MP0002060_abnormal_skin_morphology | 0.95397971 |
| 103 | MP0006138_congestive_heart_failure | 0.92607449 |
| 104 | MP0004883_abnormal_blood_vessel | 0.92483691 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.91032077 |
| 106 | MP0004085_abnormal_heartbeat | 0.89603521 |
| 107 | MP0000163_abnormal_cartilage_morphology | 0.89574283 |
| 108 | MP0005508_abnormal_skeleton_morphology | 0.89263880 |
| 109 | MP0006292_abnormal_olfactory_placode | 0.89019353 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.88204684 |
| 111 | MP0003828_pulmonary_edema | 0.87718925 |
| 112 | MP0001243_abnormal_dermal_layer | 0.87611856 |
| 113 | MP0001661_extended_life_span | 0.85977155 |
| 114 | MP0001849_ear_inflammation | 0.85230942 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.84920926 |
| 116 | MP0003942_abnormal_urinary_system | 0.83814086 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.82025592 |
| 118 | MP0001614_abnormal_blood_vessel | 0.82016099 |
| 119 | MP0003953_abnormal_hormone_level | 0.79419909 |
| 120 | MP0000569_abnormal_digit_pigmentation | 0.79416745 |
| 121 | MP0004484_altered_response_of | 0.79233814 |
| 122 | MP0002116_abnormal_craniofacial_bone | 0.79019594 |
| 123 | MP0002168_other_aberrant_phenotype | 0.78804771 |
| 124 | MP0002115_abnormal_skeleton_extremities | 0.75513390 |
| 125 | MP0003252_abnormal_bile_duct | 0.74787972 |
| 126 | MP0009053_abnormal_anal_canal | 0.73928835 |
| 127 | MP0009697_abnormal_copulation | 0.73312146 |
| 128 | MP0005408_hypopigmentation | 0.72979731 |
| 129 | MP0005390_skeleton_phenotype | 0.72504327 |
| 130 | MP0002972_abnormal_cardiac_muscle | 0.71801648 |
| 131 | MP0003879_abnormal_hair_cell | 0.71571784 |
| 132 | MP0001346_abnormal_lacrimal_gland | 0.71451359 |
| 133 | MP0005388_respiratory_system_phenotype | 0.71437347 |
| 134 | MP0002133_abnormal_respiratory_system | 0.71437347 |
| 135 | MP0008995_early_reproductive_senescence | 0.70799476 |
| 136 | MP0005167_abnormal_blood-brain_barrier | 0.70567648 |
| 137 | MP0000049_abnormal_middle_ear | 0.70205458 |
| 138 | MP0000249_abnormal_blood_vessel | 0.69188116 |
| 139 | MP0002925_abnormal_cardiovascular_devel | 0.68860430 |
| 140 | MP0000681_abnormal_thyroid_gland | 0.68679226 |
| 141 | MP0002109_abnormal_limb_morphology | 0.67940678 |
| 142 | MP0001175_abnormal_lung_morphology | 0.67552677 |
| 143 | MP0003755_abnormal_palate_morphology | 0.67334062 |
| 144 | MP0001756_abnormal_urination | 0.67292982 |
| 145 | MP0002233_abnormal_nose_morphology | 0.67021630 |
| 146 | MP0000432_abnormal_head_morphology | 0.66287451 |
| 147 | MP0005085_abnormal_gallbladder_physiolo | 0.65981290 |
| 148 | MP0002102_abnormal_ear_morphology | 0.65902929 |
| 149 | MP0005197_abnormal_uvea_morphology | 0.65751062 |
| 150 | MP0000733_abnormal_muscle_development | 0.65336552 |
| 151 | MP0001502_abnormal_circadian_rhythm | 0.64069277 |
| 152 | MP0005381_digestive/alimentary_phenotyp | 0.63396937 |
| 153 | MP0002127_abnormal_cardiovascular_syste | 0.63337488 |
| 154 | MP0003448_altered_tumor_morphology | 0.62736154 |
| 155 | MP0005165_increased_susceptibility_to | 0.62306059 |
| 156 | MP0000427_abnormal_hair_cycle | 0.59976571 |
| 157 | MP0000465_gastrointestinal_hemorrhage | 0.59801541 |
| 158 | MP0001851_eye_inflammation | 0.59325526 |
| 159 | MP0004130_abnormal_muscle_cell | 0.58176781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.17954393 |
| 2 | Symptomatic seizures (HP:0011145) | 5.42385708 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.36327307 |
| 4 | Increased mean platelet volume (HP:0011877) | 5.34759671 |
| 5 | Protrusio acetabuli (HP:0003179) | 4.95209729 |
| 6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.83678113 |
| 7 | Decreased circulating renin level (HP:0003351) | 4.74169665 |
| 8 | Abnormal platelet volume (HP:0011876) | 4.70235517 |
| 9 | Vascular tortuosity (HP:0004948) | 4.57478776 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 4.43146974 |
| 11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.36936050 |
| 12 | Menorrhagia (HP:0000132) | 4.33982113 |
| 13 | Follicular hyperkeratosis (HP:0007502) | 4.32511247 |
| 14 | Hypoglycemic seizures (HP:0002173) | 4.32010332 |
| 15 | Arterial tortuosity (HP:0005116) | 4.24583127 |
| 16 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.00863115 |
| 17 | Intestinal atresia (HP:0011100) | 3.80947798 |
| 18 | Ankle contracture (HP:0006466) | 3.78874331 |
| 19 | Soft skin (HP:0000977) | 3.78347182 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.61644717 |
| 21 | Hyperglycemia (HP:0003074) | 3.59627673 |
| 22 | Hypokalemia (HP:0002900) | 3.50360274 |
| 23 | Abnormality of renin-angiotensin system (HP:0000847) | 3.37729013 |
| 24 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.30611504 |
| 25 | Thin bony cortex (HP:0002753) | 3.17558980 |
| 26 | Osteomalacia (HP:0002749) | 3.11396956 |
| 27 | Hypoplastic labia majora (HP:0000059) | 3.11019511 |
| 28 | Hyperactive renin-angiotensin system (HP:0000841) | 3.08501224 |
| 29 | Midline defect of the nose (HP:0004122) | 3.07846854 |
| 30 | Slender build (HP:0001533) | 3.03127190 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.01036610 |
| 32 | Abnormality of the right ventricle (HP:0001707) | 3.00666713 |
| 33 | Abnormal pancreas size (HP:0012094) | 3.00311482 |
| 34 | Bladder diverticulum (HP:0000015) | 2.96311328 |
| 35 | Overgrowth (HP:0001548) | 2.95350877 |
| 36 | Hyperparathyroidism (HP:0000843) | 2.95291623 |
| 37 | Large for gestational age (HP:0001520) | 2.95169728 |
| 38 | Spinal rigidity (HP:0003306) | 2.94476049 |
| 39 | Spondylolisthesis (HP:0003302) | 2.93611639 |
| 40 | Abnormality of potassium homeostasis (HP:0011042) | 2.92021031 |
| 41 | Wormian bones (HP:0002645) | 2.89149987 |
| 42 | Abnormality of the labia majora (HP:0012881) | 2.87420237 |
| 43 | Petechiae (HP:0000967) | 2.86522510 |
| 44 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.86345582 |
| 45 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.86345582 |
| 46 | Hypoglycemic coma (HP:0001325) | 2.83494797 |
| 47 | Abnormality of dentin (HP:0010299) | 2.82435403 |
| 48 | Gingival bleeding (HP:0000225) | 2.76394726 |
| 49 | Neonatal short-limb short stature (HP:0008921) | 2.74746266 |
| 50 | Dilatation of the ascending aorta (HP:0005111) | 2.65749586 |
| 51 | Aortic aneurysm (HP:0004942) | 2.63626929 |
| 52 | Unilateral renal agenesis (HP:0000122) | 2.63618956 |
| 53 | Increased variability in muscle fiber diameter (HP:0003557) | 2.63137661 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.61708222 |
| 55 | Cervical subluxation (HP:0003308) | 2.61197217 |
| 56 | Widely patent fontanelles and sutures (HP:0004492) | 2.60847660 |
| 57 | Hyperkalemia (HP:0002153) | 2.57444882 |
| 58 | Mesomelia (HP:0003027) | 2.54738676 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.54256736 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.54256736 |
| 61 | Epistaxis (HP:0000421) | 2.53586169 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.52945893 |
| 63 | Hypoventilation (HP:0002791) | 2.52714215 |
| 64 | Long toe (HP:0010511) | 2.52382554 |
| 65 | Absent eyebrow (HP:0002223) | 2.51469892 |
| 66 | Mitral valve prolapse (HP:0001634) | 2.50961773 |
| 67 | Shawl scrotum (HP:0000049) | 2.49784937 |
| 68 | Wide anterior fontanel (HP:0000260) | 2.48431548 |
| 69 | Hydroureter (HP:0000072) | 2.43656810 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.41746637 |
| 71 | Bowel diverticulosis (HP:0005222) | 2.33622317 |
| 72 | Volvulus (HP:0002580) | 2.32543644 |
| 73 | Shallow orbits (HP:0000586) | 2.27335805 |
| 74 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.24178939 |
| 75 | Joint laxity (HP:0001388) | 2.23430535 |
| 76 | Blue sclerae (HP:0000592) | 2.21713277 |
| 77 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.21441811 |
| 78 | Abnormal delivery (HP:0001787) | 2.19865336 |
| 79 | Abdominal distention (HP:0003270) | 2.19537843 |
| 80 | Papillary thyroid carcinoma (HP:0002895) | 2.19154561 |
| 81 | Abnormal biliary tract morphology (HP:0012440) | 2.18883845 |
| 82 | Hypothermia (HP:0002045) | 2.18027048 |
| 83 | Nemaline bodies (HP:0003798) | 2.15149355 |
| 84 | Anteriorly placed anus (HP:0001545) | 2.14819073 |
| 85 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12859004 |
| 86 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.12641263 |
| 87 | Hypoplasia of the fovea (HP:0007750) | 2.12641263 |
| 88 | Peritonitis (HP:0002586) | 2.11272060 |
| 89 | Flat capital femoral epiphysis (HP:0003370) | 2.11063447 |
| 90 | Aortic dissection (HP:0002647) | 2.10972582 |
| 91 | Complete atrioventricular canal defect (HP:0001674) | 2.09752167 |
| 92 | Mitral stenosis (HP:0001718) | 2.08037366 |
| 93 | Short hallux (HP:0010109) | 2.07145454 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.05737212 |
| 95 | Abnormality of chloride homeostasis (HP:0011422) | 2.05409816 |
| 96 | Purpura (HP:0000979) | 2.04466527 |
| 97 | Increased corneal curvature (HP:0100692) | 2.04241154 |
| 98 | Keratoconus (HP:0000563) | 2.04241154 |
| 99 | Papilledema (HP:0001085) | 2.02532089 |
| 100 | Muscle fiber inclusion bodies (HP:0100299) | 2.01877812 |
| 101 | Labial hypoplasia (HP:0000066) | 1.99923218 |
| 102 | Coronal craniosynostosis (HP:0004440) | 1.99319458 |
| 103 | Hyperextensible skin (HP:0000974) | 1.98966581 |
| 104 | Hyperphosphatemia (HP:0002905) | 1.98279962 |
| 105 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.97033854 |
| 106 | Subacute progressive viral hepatitis (HP:0006572) | 1.95058637 |
| 107 | Limited hip movement (HP:0008800) | 1.94161405 |
| 108 | Enlarged epiphyses (HP:0010580) | 1.93273507 |
| 109 | Wide cranial sutures (HP:0010537) | 1.92303361 |
| 110 | Congenital glaucoma (HP:0001087) | 1.92237367 |
| 111 | Bruising susceptibility (HP:0000978) | 1.90926344 |
| 112 | Conjunctival telangiectasia (HP:0000524) | 1.90419561 |
| 113 | Abnormality of the fovea (HP:0000493) | 1.88736862 |
| 114 | Metabolic alkalosis (HP:0200114) | 1.88093094 |
| 115 | Atrioventricular canal defect (HP:0006695) | 1.87175308 |
| 116 | Lip pit (HP:0100267) | 1.86566506 |
| 117 | Spontaneous hematomas (HP:0007420) | 1.85787125 |
| 118 | Increased density of long bones (HP:0006392) | 1.83034997 |
| 119 | Tibial bowing (HP:0002982) | 1.82722802 |
| 120 | Camptodactyly of toe (HP:0001836) | 1.81936613 |
| 121 | Hypocalcemia (HP:0002901) | 1.81533817 |
| 122 | Striae distensae (HP:0001065) | 1.81294980 |
| 123 | Increased circulating renin level (HP:0000848) | 1.81074393 |
| 124 | Hypoalphalipoproteinemia (HP:0003233) | 1.80490513 |
| 125 | Genu recurvatum (HP:0002816) | 1.80147609 |
| 126 | Fragile skin (HP:0001030) | 1.79649533 |
| 127 | Mild short stature (HP:0003502) | 1.78841901 |
| 128 | Round ear (HP:0100830) | 1.76962779 |
| 129 | Facial diplegia (HP:0001349) | 1.76236717 |
| 130 | Chronic bronchitis (HP:0004469) | 1.76022288 |
| 131 | Atonic seizures (HP:0010819) | 1.74818329 |
| 132 | Neoplasm of the heart (HP:0100544) | 1.74582323 |
| 133 | Broad ribs (HP:0000885) | 1.74352241 |
| 134 | Cystic liver disease (HP:0006706) | 1.74329691 |
| 135 | Hypophosphatemia (HP:0002148) | 1.74225552 |
| 136 | Hypoplastic female external genitalia (HP:0012815) | 1.74134806 |
| 137 | Insulin resistance (HP:0000855) | 1.73805934 |
| 138 | Abnormality of the common coagulation pathway (HP:0010990) | 1.73574042 |
| 139 | Aneurysm (HP:0002617) | 1.73278506 |
| 140 | Hematochezia (HP:0002573) | 1.73153540 |
| 141 | Knee flexion contracture (HP:0006380) | 1.72549377 |
| 142 | Abnormality of the fingertips (HP:0001211) | 1.72060780 |
| 143 | Elbow flexion contracture (HP:0002987) | 1.70614943 |
| 144 | Persistence of primary teeth (HP:0006335) | 1.70550697 |
| 145 | Thoracolumbar scoliosis (HP:0002944) | 1.69597757 |
| 146 | Hip contracture (HP:0003273) | 1.69267881 |
| 147 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.69170583 |
| 148 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.69170583 |
| 149 | Single umbilical artery (HP:0001195) | 1.69170583 |
| 150 | Hypoplasia of the iris (HP:0007676) | 1.69114669 |
| 151 | Abnormal platelet function (HP:0011869) | 1.68546149 |
| 152 | Impaired platelet aggregation (HP:0003540) | 1.68546149 |
| 153 | Abnormality of the metopic suture (HP:0005556) | 1.67909128 |
| 154 | Progressive sensorineural hearing impairment (HP:0000408) | 1.67809842 |
| 155 | Hyperaldosteronism (HP:0000859) | 1.66744199 |
| 156 | Broad metatarsal (HP:0001783) | 1.65865588 |
| 157 | Bradycardia (HP:0001662) | 1.64849754 |
| 158 | Gastrointestinal atresia (HP:0002589) | 1.63730125 |
| 159 | Pulmonary artery stenosis (HP:0004415) | 1.63379358 |
| 160 | Acanthocytosis (HP:0001927) | 1.62921357 |
| 161 | Tetany (HP:0001281) | 1.62424834 |
| 162 | Femoral bowing (HP:0002980) | 1.62380596 |
| 163 | Distal arthrogryposis (HP:0005684) | 1.61840678 |
| 164 | Cerebral aneurysm (HP:0004944) | 1.61317348 |
| 165 | Popliteal pterygium (HP:0009756) | 1.61124415 |
| 166 | Cutaneous finger syndactyly (HP:0010554) | 1.60898289 |
| 167 | Protruding ear (HP:0000411) | 1.60320523 |
| 168 | Abnormality of the nasal septum (HP:0000419) | 1.59436901 |
| 169 | Hypoplasia of dental enamel (HP:0006297) | 1.59366809 |
| 170 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.59046300 |
| 171 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.59046300 |
| 172 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.59046300 |
| 173 | Progressive hearing impairment (HP:0001730) | 1.58593446 |
| 174 | Potter facies (HP:0002009) | 1.57510253 |
| 175 | Facial shape deformation (HP:0011334) | 1.57510253 |
| 176 | Agitation (HP:0000713) | 1.56530327 |
| 177 | Atrophic scars (HP:0001075) | 1.56384982 |
| 178 | Prominent metopic ridge (HP:0005487) | 1.55593661 |
| 179 | Villous atrophy (HP:0011473) | 1.55271516 |
| 180 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.55271516 |
| 181 | Ketoacidosis (HP:0001993) | 1.51983520 |
| 182 | Micronodular cirrhosis (HP:0001413) | 1.50671194 |
| 183 | Metaphyseal irregularity (HP:0003025) | 1.50426075 |
| 184 | Chronic hepatic failure (HP:0100626) | 1.49245581 |
| 185 | Aortic regurgitation (HP:0001659) | 1.47783981 |
| 186 | Cranial hyperostosis (HP:0004437) | 1.45517543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.59568044 |
| 2 | FRK | 4.37361764 |
| 3 | TAOK3 | 4.03820833 |
| 4 | PASK | 3.24622923 |
| 5 | IRAK3 | 2.79488394 |
| 6 | GRK7 | 2.54237464 |
| 7 | PRKD3 | 2.47748406 |
| 8 | LATS1 | 2.47358563 |
| 9 | NUAK1 | 2.40433733 |
| 10 | ACVR1B | 2.28607261 |
| 11 | AKT3 | 2.23685057 |
| 12 | EPHA3 | 2.23587357 |
| 13 | HIPK2 | 2.14093332 |
| 14 | GRK5 | 2.07258331 |
| 15 | PDGFRA | 2.01920539 |
| 16 | MAP3K2 | 2.00629520 |
| 17 | TIE1 | 1.90346335 |
| 18 | CDC42BPA | 1.88255711 |
| 19 | ADRBK1 | 1.79184141 |
| 20 | MAPK15 | 1.78535192 |
| 21 | ADRBK2 | 1.77713332 |
| 22 | MYLK | 1.76752120 |
| 23 | PTK6 | 1.64472848 |
| 24 | BRD4 | 1.59489494 |
| 25 | PTK2B | 1.53595745 |
| 26 | MST4 | 1.43255641 |
| 27 | TRPM7 | 1.39531095 |
| 28 | ZAK | 1.38074179 |
| 29 | DMPK | 1.29459673 |
| 30 | EPHB2 | 1.29009912 |
| 31 | CAMKK2 | 1.26226270 |
| 32 | BMX | 1.25740306 |
| 33 | IRAK1 | 1.19633865 |
| 34 | FLT3 | 1.18103901 |
| 35 | FER | 1.14311278 |
| 36 | PNCK | 1.14308890 |
| 37 | PLK2 | 1.13861195 |
| 38 | PRKCH | 1.11260153 |
| 39 | IRAK2 | 1.08734658 |
| 40 | MAP3K1 | 1.06417847 |
| 41 | ILK | 1.05872431 |
| 42 | PRKD2 | 1.05601933 |
| 43 | PTK2 | 1.05073229 |
| 44 | NLK | 0.98947568 |
| 45 | RIPK1 | 0.96479598 |
| 46 | STK24 | 0.93878869 |
| 47 | CASK | 0.92908291 |
| 48 | STK38 | 0.82974851 |
| 49 | TNIK | 0.82675646 |
| 50 | TEC | 0.81602588 |
| 51 | SGK2 | 0.81420057 |
| 52 | WNK1 | 0.81268673 |
| 53 | NTRK1 | 0.78700041 |
| 54 | PDGFRB | 0.78364314 |
| 55 | FGFR3 | 0.78213001 |
| 56 | NTRK3 | 0.77930464 |
| 57 | BRSK2 | 0.77837164 |
| 58 | PRKCE | 0.76347074 |
| 59 | DAPK3 | 0.75652529 |
| 60 | DDR2 | 0.75280485 |
| 61 | STK3 | 0.74078108 |
| 62 | IRAK4 | 0.71377622 |
| 63 | MAP3K12 | 0.71250870 |
| 64 | STK38L | 0.71136527 |
| 65 | MAP2K1 | 0.69862205 |
| 66 | OBSCN | 0.68098639 |
| 67 | CHUK | 0.66799393 |
| 68 | FGFR2 | 0.66521366 |
| 69 | JAK1 | 0.66406308 |
| 70 | ITK | 0.65923420 |
| 71 | UHMK1 | 0.64791084 |
| 72 | WNK4 | 0.64179152 |
| 73 | TTN | 0.63440172 |
| 74 | MARK2 | 0.61815193 |
| 75 | MKNK2 | 0.61133245 |
| 76 | SGK3 | 0.60390496 |
| 77 | GRK6 | 0.59712014 |
| 78 | STK4 | 0.59253021 |
| 79 | ROCK2 | 0.58328820 |
| 80 | PRKAA1 | 0.57533697 |
| 81 | LMTK2 | 0.57129795 |
| 82 | TGFBR2 | 0.55257656 |
| 83 | CDK3 | 0.54939993 |
| 84 | CDK12 | 0.54634838 |
| 85 | MAP2K2 | 0.54225900 |
| 86 | PRKG2 | 0.53986051 |
| 87 | BMPR1B | 0.52969441 |
| 88 | GSK3A | 0.52498792 |
| 89 | ERBB4 | 0.51749979 |
| 90 | MAPKAPK3 | 0.50698314 |
| 91 | PRKAA2 | 0.50084298 |
| 92 | LIMK1 | 0.49373056 |
| 93 | MELK | 0.49072156 |
| 94 | ERBB3 | 0.48815037 |
| 95 | STK39 | 0.48313720 |
| 96 | SCYL2 | 0.48221266 |
| 97 | MET | 0.47739615 |
| 98 | GRK1 | 0.47029541 |
| 99 | KIT | 0.45800901 |
| 100 | CAMK1G | 0.45024940 |
| 101 | PAK1 | 0.44467155 |
| 102 | PIK3CG | 0.44116525 |
| 103 | ERBB2 | 0.43193894 |
| 104 | MAPK13 | 0.43066987 |
| 105 | PRKD1 | 0.42503093 |
| 106 | PIK3CA | 0.42020353 |
| 107 | CDK9 | 0.41785759 |
| 108 | * PRKG1 | 0.41727758 |
| 109 | RET | 0.40707753 |
| 110 | PAK3 | 0.39558636 |
| 111 | TGFBR1 | 0.38989929 |
| 112 | NEK6 | 0.38869780 |
| 113 | CSNK1A1L | 0.38860377 |
| 114 | IGF1R | 0.37611524 |
| 115 | PRKDC | 0.37489470 |
| 116 | CAMK1D | 0.37404876 |
| 117 | PAK2 | 0.37213676 |
| 118 | RPS6KA2 | 0.36276024 |
| 119 | CAMK2D | 0.36259907 |
| 120 | SGK494 | 0.35786099 |
| 121 | SGK223 | 0.35786099 |
| 122 | WNK3 | 0.34959965 |
| 123 | TXK | 0.34662072 |
| 124 | MAP3K7 | 0.34616599 |
| 125 | ROCK1 | 0.34416823 |
| 126 | RPS6KB1 | 0.34124040 |
| 127 | AKT1 | 0.33924220 |
| 128 | MAPK14 | 0.33821366 |
| 129 | ATM | 0.33255427 |
| 130 | SRPK1 | 0.32685597 |
| 131 | YES1 | 0.32603883 |
| 132 | MAP3K5 | 0.32308565 |
| 133 | BCR | 0.32264083 |
| 134 | CSNK1A1 | 0.31102407 |
| 135 | MTOR | 0.31027016 |
| 136 | NEK9 | 0.30319686 |
| 137 | CDK8 | 0.29817388 |
| 138 | CAMK2G | 0.29218447 |
| 139 | PKN2 | 0.29001228 |
| 140 | EIF2AK1 | 0.28921716 |
| 141 | CSF1R | 0.28616247 |
| 142 | FGFR1 | 0.28347722 |
| 143 | ZAP70 | 0.27125385 |
| 144 | CAMK2A | 0.25360569 |
| 145 | PRKCB | 0.24546064 |
| 146 | INSR | 0.24225823 |
| 147 | ABL1 | 0.22962474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.81836212 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.96513451 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.89871755 |
| 4 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.29825851 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.29152339 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.08610262 |
| 7 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 2.05459703 |
| 8 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.88871684 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 1.74515699 |
| 10 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.59131126 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 1.56651521 |
| 12 | Melanoma_Homo sapiens_hsa05218 | 1.56082824 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.50635815 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41446309 |
| 15 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.38174916 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35433150 |
| 17 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.31552139 |
| 18 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.30115472 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22599334 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.21139164 |
| 21 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.21012330 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19857439 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18941014 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17303376 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14317113 |
| 26 | Adherens junction_Homo sapiens_hsa04520 | 1.10526259 |
| 27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10487321 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10382084 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10152003 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09234454 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08995297 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.08808100 |
| 33 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08100096 |
| 34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03752878 |
| 35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03398753 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02220113 |
| 37 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.01998833 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.00947720 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.00414443 |
| 40 | Glioma_Homo sapiens_hsa05214 | 0.99343282 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98459449 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96515800 |
| 43 | Prostate cancer_Homo sapiens_hsa05215 | 0.95617666 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95602420 |
| 45 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95269129 |
| 46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95116199 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93306135 |
| 48 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92406319 |
| 49 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.90929774 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 0.90725598 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87006789 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.86612485 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86247612 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 0.85056301 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 0.84430984 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84041278 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81497408 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80751650 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.79257510 |
| 60 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78792293 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.78075304 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77248011 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76831627 |
| 64 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.76116385 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75900381 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74296104 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71143804 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70958894 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70765584 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68718995 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68502452 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68356125 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68340744 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68153391 |
| 75 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.67080885 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66929077 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65777753 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.65206553 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.64153133 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64061949 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.62456959 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62297270 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61890978 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61727627 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61465533 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60919710 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58291427 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57631193 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | 0.57616320 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57085025 |
| 91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56967662 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56324780 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54927547 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.53917582 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.52618513 |
| 96 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51407962 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51207071 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51205219 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.50448235 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50405319 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50185676 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49717514 |
| 103 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49595789 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49384397 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49221976 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.48803878 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48425784 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48164738 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.48080431 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47517603 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.47266173 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46989848 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46619775 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46500592 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46075043 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.45780856 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44414567 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44250873 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.43998793 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.43104959 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42859050 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41916033 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41060444 |
| 124 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40839879 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40655588 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40064206 |
| 127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39929772 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39642385 |
| 129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39320203 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38895791 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38265715 |
| 132 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37716511 |

